Recalls / Class II
Class IID-0603-2024
Product
Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2080-10
- Affected lot / code info
- Lot#: 8147041; Exp. June 2024 Lot#: 8163765; Exp. March 2025
Why it was recalled
Failed Impurities/Degradation Specifications
Recalling firm
- Firm
- Viatris Inc
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 1000 Mylan Blvd, Canonsburg, Pennsylvania 15317-5853
Distribution
- Quantity
- 3,694 bottles
- Distribution pattern
- U.S. Nationwide
Timeline
- Recall initiated
- 2024-04-30
- FDA classified
- 2024-07-16
- Posted by FDA
- 2024-07-24
- Status
- Completed
Source: openFDA Drug Enforcement endpoint. Recall record D-0603-2024. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.